Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-06-07
2000-11-14
Chambers, Jasemine
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
514 44, 435325, 435455, 435 691, 4353201, A01N 4304, A61K 3170, C12N 1563, C12N 1500
Patent
active
061466239
ABSTRACT:
A composition comprising genetically altered human neutrophil precursor cells, wherein the cellular component is comprised of at least about 16% human myeloblasts and promyelocytes, which have been derived from neutrophil progenitor cells obtained from peripheral blood, bone marrow or cord blood, and less than about 5% colony forming units (CFU) of at least about 50 cells is provided. An alternative composition comprising genetically altered human neutrophil precursor cells, wherein the cellular component is comprised of at least about 16% CD15+CD11b- cells and less than about 5% colony forming units (CFU) of at least about 50 cells also is provided, wherein at least about 60% of the CD15+CD11b- cells are myeloblasts and promyelocytes.
REFERENCES:
patent: 4714680 (1987-12-01), Civin
patent: 4965204 (1990-10-01), Civin
patent: 5004681 (1991-04-01), Boyse et al.
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5079228 (1992-01-01), Cohen et al.
patent: 5087570 (1992-02-01), Weissman et al.
patent: 5199942 (1993-04-01), Gillis
patent: 5399493 (1995-03-01), Emerson et al.
patent: 5437994 (1995-08-01), Emerson et al.
patent: 5605822 (1997-02-01), Emerson et al.
patent: 5646043 (1997-07-01), Emerson et al.
patent: 5670147 (1997-09-01), Emerson et al.
patent: 5670351 (1997-09-01), Emerson et al.
"The Use of recombinant cytokines for enhancing immunohematopietic reconstitution following BMT. I. Effect of in vitro culturing with IL-3 and GM-CSF on human mouse BM cells purged with mafosfamide (ASTA-Z)," Bone Marrow Transplantation 4:459-464 (1989).
Bender et al., "Identification and Comparison of CD34-Positive Cells and Their Subpopulations From Normal Peripheral Blood and Bone Marrow Using Multicolor Flow Cytometry,"Blood 77 (12):2591-2596 (1991).
Brandt et al., "Role of c-kit Ligand in the Expansion of Human Hematopoietic Progenitor Cells," Blood 79 (3):634-641 (1992).
Nilsson & Olofsson, "Proliferation and differentiation of normal and chronic myeloid leukaemia (CML) marrow cells in suspension cultures," Scand. J. Haematol 32:231-240 (1984).
Orkin et al., Report and Recommendations of the Panel To Assess the NIH Investment in Research on Gene Therapy, Dec. 7, 1995.
Coghlan, Focus, vol. 148, pp. 14-15, Nov. 25, 1995.
Brown, "News Media, Researches 'Oversold " Gene Therapy, Advisory Panel Says", The Washington Post, Dec. 8, 1995.
Marshall, Science, vol. 269, pp. 1050-1055, Aug. 25, 1995.
Schmidt-Wolf, Journal of Hematotherapy, vol. 4, pp. 551-561, 1995.
Mickisch et al., PNAS, vol. 88, pp. 547-551, Jan. 15, 1991.
Fletcher et al., Journal of Experimental Medicine, vol. 174, pp. 837-845, Oct. 1, 1991.
Egeland et al., "Myeloid Differentiation of Purified CD34.sub.+ Cells After Stimulation with Recombinant Human Granulocyte-Monocyte Colony-Stimulating Factor (CSF), Granulocyte-CSF, Monocyte-CSF, and Interleukin-3, " Blood 78 (12):3192-3199 (1991).
Buckner et al., "Prophylaxis and Treatment of Infection of the Immunocomprised Host by Granulocyte Transfusions," Clinics in Haematology 13 (3), ch. 3, pp. 557-572 (1984).
Clift et al., "Granuloycte Transfusions," The American J. of Med. 76:631-636 (1984).
Douay et al., "Recovery of CFU-GM from Cryopreserved Marrow and in vivo Evaluation after Autologous Bone Marrow Transplantation are Predictive of Engraftment," Exp. Hematol. 14:358-365 (1986).
Fabian et al., "Enhanced Reconstitution of Hematopoietic Organs in Irradiated Mice, Following Their Transplantation with Bone Marrow Cells Pretreated with Recombinant Interleukin 3," Exp. Hematol. 15:1140-1144 (1987).
Frenck et al., "Studies of the Function and Structure of In Vitro Propagated Human Granulocytes," Pediatric Res. 30 (2):135-140 (1991).
Juttner et al., "Early Lympho-Hemopoietic Recovery After Autografting Using Peripheral Blood Stem Cells in Acute Non-Lymphoblastic Leukemia," 20 (1):40-43 (1988).
Knapp, Eds. W., Leucocyte Typing IV: White Cell Differentiation Antigens, Oxford University Press, p. 1083 (1989).
Koeffler et al., "Human Myeloid Leukemia Cell Lines: A Review, " Blood 56 (3):344-350 (1980).
Lasky et al., "In Vitro Treatment of Peripheral Blood Stem Cells to Increase Committed Progenitor Content," Exp. Hematol., vol. 17, Abs. 239, p. 587 (1989).
Ling et al., "Human Fibroblasts Maintain the Viability and Augment the Functional Response of Human Neutrophils in Culture," J. Clin. Invest., 78:601-604 (1990).
Lopez et al., "Recombinant Human GM-CSF Stimulated In Vitro Mature Human Neutrophil and Eosinophil Function, Surface Receptor Expression, and Survival, " J. Clin. Invest., 78:1220-1228 (1986).
Menitove et al., "Granulocyte Transfusions in Neutropenic Patients," CRC Critical Reviews in Oncology/Hematology 7(1):89-113 (1987).
Nakaya et al., "The Influence of Histamine on Precursors of Granulocytic Leukocytes in Murine Bone Marrow," Life sci. 42(9):999-1010 (1988).
Nilsson et al., "Proliferation and Differentiation in Diffusion Chambers of Marrow Blood and Spleen Cells from Patients with Chronic Myeloid Leukemia During Chronic Phase and Blastic Transformation," Scand. J. Hematol. 24(5):381-392 (1980) (Abstract Only).
Nilsson et al., "Proliferation and Differentiation of Normal and Chronic Myeloid Leukaemia (CML) Marrow Cells in Suspension Cultures," Scand. J. Haematol. 32(3):231-240 (1984) (Abstract Only).
Okabe-Kado et al., "Induction of Differentiation of Mouse Myeloid Leukemia M1 Cells by Serum of Patients with Chornic Myeloid Leukemia," Jpn. J. Canc. Res. 79(12):1318-1326 (1988).
Okano et al., "In Vitro Expansion of the Murine Pluripotent Hemapoietic Stem Cell Population in Response to Interleukin 3 and Interleukin 6", Transplantation 48(3):495-498 (1989).
Ottmann et al., "Expansion of Hematopoietic Progenitor Cells (Pre-CFU) in Serum-Free Culture: Modulation by Cytokines and Stromal Elements," Exp. Hematol. 17(240):587 (1989).
Robinson et al., "Single Donor Granulocytes and Platelets," Clinics in Haematology 13(1):185-216 (ch. 11) (1984).
Saeland et al., "Effects of Recombinant Human Interleukin-3 on CD34-Enriched Normal Hematopoietic Progenitors and on Myeloblastic Leukemia Cells," Blood 72(5):1580-1588 (1988).
Saeland et al., "Combined and Sequential Effects of Human IL-3 and GM-CSF on the Proliferation of CD34+ Hematopoietic Cells From Cord Blood," Blood 73(5):1195-1201 (1989).
Serke et al., "A liquid culture method for the in vitro growth of hemopoietic progenitor cells . . . allowing for analysis by multiparameter flow-cytomery," Eur. J. Haematol.,46:85-92 (1991).
Sheridan et al., "Granulocyte Colony-Stimulating Factor (G-CSF) in Peripheral Blood Stem Cell (PBSC) and Bone Marrow (BM) Transplantation," Blood vol. 76, Supp II, Abs. 2251, 565a (1990).
Slavin et al., "The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effect of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z), " Bone Marrow Transplantation 4:459-464 (1989).
Spizter et al., "The Myeloid Progenitor Cell-Its Value in Predicting Hematopoietic Recovery After Autologous Bone Marrow Transplantation," Blood 55(2):317-323 (1980).
Strauss et al., "Selection of Normal Human Hematopoietic Stem Cells for BMT Using Immunomagnetic Microspheres and CD34 Antibody," Amer. J. Ped. Hemat./Onc., 13(2):217-221 (1991).
Tavassoli et al., "Enhancement of the Grafting Efficiency of Transplanted Marrow Cells by Preincubation With Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor," 77(7):1599-1606 (1991).
Terstappen et al., "Differentiation and Maturation of Growth Factor Expanded Early Human Hematopoietic Progenitors Assessed by Multidimensional Flow Cytometry," Blood vol. 78(10), Supp I, Abs. 1182, 298a.
Terstappen et al., "Flow Cytometric Analysis of Human Bone Marrow III. Neutrophil Maturation," Leukemia 4(9):657-663 (1990).
Treves et al., "A New Myelomonoblastic Cell Line M-20 Analysis of Properties Differentiation and Comparison with Other Established Lines of Similar Origin," Exp. Hematol. 13(4):281-288 (1985).
Wagemaker, G., "Selective Multiplication of Hematopoietic Stem Cel
Bender James G.
Maples Phillip B.
Smith Stephen
Unverzagt Kristen L.
Van Epps Dennis E.
Chambers Jasemine
Martin Jill D.
Nexell Therapeutics Inc.
LandOfFree
In vitro-derived genetically altered human neutrophil precursor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vitro-derived genetically altered human neutrophil precursor , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro-derived genetically altered human neutrophil precursor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062276